Researchers evaluated sex differences in clinical features and chromosomal abnormalities in 850 patients with newly diagnosed multiple myeloma.
Rates of multiple myeloma (MM), the second most common blood cancer in the United States, are increasing and are twice as ...
Abstract: State-of-the-art CubeSat electric power system (EPS) architectures employ multiple dc-dc converters to regulate the load voltage and maximize the solar energy harvest. However, this leads to ...
Multiple sclerosis (MS) is a chronic neurological disease characterized by nerve damage and consequent impairments in vision, ...
US FDA grants fast track designation to Complement Therapeutics’ gene therapy candidate CTx001 to treat geographic atrophy: Munich Saturday, January 10, 2026, 17:00 Hrs [IST] Co ...
aps the immune cell landscape of bone marrow in patients with multiple myeloma, a rare cancer that develops in the plasma ...
Complement Therapeutics GmbH (CTx), a clinical-stage biotechnology company developing next-generation therapeutics for complement-mediated diseases, today announced that the U.S. Food and Drug ...
There may be two distinct subtypes of multiple sclerosis, according to a new study led by scientists at University College ...
Earlier this week, Johnston said he was turned away from emergency rooms and fears that he could die before receiving a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback